Urology Doctors in State College, PA Accepting Medicare

8 Urology doctors found. Showing 1 - 8

Dr. Daniel R Pitts, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 905 University Dr, State College, PA 16801 Phone: 814-238-8418    Fax: 814-234-2888

Scott Geiger, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 905 University Dr, State College, PA 16801 Phone: 814-238-8418    Fax: 814-234-2888

Stephen Harry Phillips Ii, D.O. Urology Medicare: Accepting Medicare Assignments Practice Location: 905 University Dr, State College, PA 16801 Phone: 814-238-8418    Fax: 814-234-2888

Robert Marshall Wild Jr., M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 905 University Dr, State College, PA 16801 Phone: 814-238-8418    Fax: 814-234-2888

David Oselinsky, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 905 University Dr, Suite 2, State College, PA 16801 Phone: 814-238-8418    Fax: 814-234-2888

Dr. Kwabena S. Ansong, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 200 Scenery Dr, State College, PA 16801 Phone: 814-231-4560    Fax: 814-235-5512

Charles Munford Dalton, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 905 University Dr, State College, PA 16801 Phone: 814-238-8418    Fax: 814-234-2888

Christopher Thomas Yingling, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 905 University Dr, State College, PA 16801 Phone: 814-238-8418    Fax: 814-234-2888

News Archive

Poll data shows disparities in older adults' ability to isolate COVID-19 persons in homes

One of the most important ways to stop the spread of COVID-19 is for people who have tested positive or have symptoms, to isolate themselves from the other people they live with.

Scientists identify signals that regulate the formation of spinal marrow

A team of researchers at Umea University in Sweden under the leadership of Thomas Edlund, Umea Center for Molecular Medicine, is now publishing their discovery of the signal molecules that regulate the formation of spinal marrow during the fetal period.

FDA lays guidelines for "biosimilar" biotech drugs

The proposed rules, issued on Thursday, require studies showing that the generic copies are "highly similar" to the originals, but there are several ways that might be proven. Because of their complexity, generic copies of biotech drugs - first introduced in the 1980s - are known as "biosimilars." The worldwide market for copies of biotech medicines will grow to $3.7 billion by 2015, from just $243 million in 2010, as more than 30 branded biologics with sales of $51 billion lose patent exclusivity, according to market analysis firm Datamonitor.

Majority of patients who appear healthy may be at risk for cardiovascular disease

Three separate studies announced today at the American Society of Hypertension Inc.'s 25th Annual Scientific Meeting and Exposition (ASH 2010) examined the cardiovascular consequences of relatively healthy patients - those who were asymptomatic and not classified as hypertensive or diabetic - and found that many patients who appear healthy may still be at risk for cardiovascular disease.

Applied Biosystems Identifiler Direct and Identifiler Plus kits approved for forensic DNA laboratories

Life Technologies Corporation today announced that its Applied Biosystems Identifiler Direct and Identifiler Plus forensic kits have been approved by the United States Federal Bureau of Investigation for use by laboratories generating DNA profiles for inclusion in the National DNA Index System CODIS Database.

Read more Medical News

› Verified 8 days ago